BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,014,222 | +23.8% | 16,066,000 | +25.8% | 0.00% | 0.0% |
| Q2 2023 | $12,932,672 | +1.8% | 12,766,000 | +4.5% | 0.00% | 0.0% |
| Q1 2023 | $12,708,502 | -60.0% | 12,216,000 | -58.5% | 0.00% | 0.0% |
| Q4 2022 | $31,770,300 | +115.6% | 29,432,000 | +100.7% | 0.00% | 0.0% |
| Q3 2022 | $14,738,000 | +13.3% | 14,666,000 | +13.1% | 0.00% | 0.0% |
| Q2 2022 | $13,012,000 | -10.6% | 12,966,000 | -9.7% | 0.00% | 0.0% |
| Q1 2022 | $14,549,000 | -9.1% | 14,366,000 | -6.5% | 0.00% | 0.0% |
| Q4 2021 | $16,006,000 | -9.2% | 15,366,000 | -12.5% | 0.00% | 0.0% |
| Q3 2021 | $17,631,000 | +14.4% | 17,566,000 | +14.7% | 0.00% | 0.0% |
| Q2 2021 | $15,414,000 | – | 15,316,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 32,443,000 | $33,719,632 | 2.49% |
| MACKAY SHIELDS LLC | 76,393,000 | $80,060,298 | 2.20% |
| Lombard Odier Asset Management (Europe) Ltd | 15,560,000 | $16,178,043 | 0.80% |
| Sonora Investment Management Group, LLC | 7,840,000 | $8,152,676 | 0.71% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 25,220,000 | $26,430,712 | 0.50% |
| ZAZOVE ASSOCIATES LLC | 3,750,000 | $3,898 | 0.36% |
| LOOMIS SAYLES & CO L P | 2,059,347 | $200,251 | 0.35% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,332,000 | $1,389,779 | 0.34% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,069 | 0.24% |
| RATIONAL ADVISORS LLC | 1,233,000 | $1,286,026 | 0.10% |